Microcapsules TRIZ Cases

Functional maleimide copolymers form stable nanodiscs that solubilize membrane proteins without detergents, preserving native structure across broad pH.

A degradable antimicrobial hydrogel expands at body temperature to fit irregular wounds, support tissue ingrowth, and avoid dressing changes.

Two aqueous dip-molded polymer layers give hard capsules gastric resistance, controlled intestinal release, and stable shell formation without solvents.

A fatty acid and weak organic acid coating protects actives in low pH, then dissolves at neutral pH for controlled release with simpler compliance.

Neutral GRAS nanoparticles with triblock copolymer coatings improve brain tissue diffusion and prolong CNS drug release.

A porous 3D scaffold bioreactor boosts extracellular vesicle yield and loading consistency for scalable GMP-ready production.

Dual-size pores and rigid nanoparticle crosslinking improve chromatographic permeability, bead strength, and biomacromolecule separation range.

Adhesive dendritic particles use multiple surface attachment points to remain at target sites and release active agents over extended periods.

An electrostatic droplet process uses poloxamer 188 during cross-linking to form smooth capsules and reduce foreign body response.

Photocleavable protecting groups on PLGA polymers enable rapid intramolecular cyclization upon UV exposure, solving slow degradation limits in drug delivery.

Tune bottlebrush block copolymer architecture to tailor nanoparticle surface topography, resolving the trade-off between blood circulation time and cell uptake.

Thermal processing converts lamellar amphiphile particles to non-lamellar forms, narrowing particle size distribution for stable intravenous drug delivery.

Non-naturally modified TREMs recognize premature termination codons and incorporate amino acids, resolving low efficiency in protein synthesis modulation.

Vicinal functional oligomers enable polymer microcapsule synthesis without formaldehyde release.

A T-Mixer combines lipid and buffer solutions to form nanoparticles with controlled size.

One-pot aqueous extraction yields dispersible exine shells, resolving the trade-off between process complexity and solution dispersibility.

An ultrasonic nebulizer generates fine liquid aerosol droplets from ionically crosslinkable polymer solutions.

Segmented Clathrin shells resolve stability-flexibility contradictions, enabling cargo attachment and blood-brain barrier crossing.

Pharmaceutical particles with gel-forming coatings create a soft surface upon contact with saliva.

Light-triggered photo-emission initiates localized polymerization to encapsulate biological cells without applying damaging shear forces.

A polysuccinimide derivative forms nanoparticles that encapsulate hydrophobic substances and release them via pH-triggered structural changes.

Shellac-coated particles encapsulate accelerators, delaying release until high pH dissolves the coating to prevent flash-setting.

Glycoprotein coatings on polymeric particles improve diffusion coefficients and reduce aggregation in mucus, increasing systemic drug uptake.

Oleo-gum resin reduces gold ions into nanoparticles while capping surfaces, boosting medicinal effectiveness without complex preparation.

An asymmetrically coated tablet maintains a constant cross-sectional area during dissolution to achieve zero-order drug release kinetics.

Zwitterionic coatings on alginate capsules enable sustained insulin secretion by improving nutrient diffusion while preventing immune rejection.

Segmented polyamide and polyester backbones enable controlled degradation into GRAS molecules while maintaining encapsulation stability.

Fluidic droplet generation creates amyloid protein capsules with controlled morphology, avoiding toxic oligomers.

Disulfide-linked polyesteramides prevent premature drug release by remaining stable in circulation and degrading only within target cells.

Transferrin and RVG coated PLGA nanoparticles transport risperidone across the blood-brain barrier, bypassing first-pass metabolism to improve bioavailability.

A bi-layer coating process applies water-soluble and insoluble polymer layers to active pharmaceutical ingredient particles.

Selective androgen receptor modulators inhibit cancer cell growth while avoiding virilizing side effects of traditional androgens.

Core-shell oxygen release microspheres deliver sustained oxygenation to ischemic tissues using a biodegradable polymer shell conjugated to catalase.

A solvent removing apparatus uses a submerged foam breaker and compressed air to accelerate evaporation during emulsion stirring.

A multi-compartment capsule delivers proton pump inhibitors and antibiotics in a single unit.

A pharmaceutical composition uses microencapsulation to deliver essential oils alongside cannabinoids.

Interfacial ring opening polymerization of N-carboxy-anhydride monomers creates strong poly(amino acid) shells with controlled particle sizes.

A two-layer coating system uses a cationic polymer outer layer to mask taste and protect acidic drug cores from moisture.

DNA/RNA hybrid nanoparticles employ trigger and exchange toeholds to conditionally release RNA payloads, addressing challenges in distinguishing aberrant cells.

A biodegradable delivery object carrier accelerates encapsulated active substances via kinetic energy for needle-free injection.

A poly(spermine acrylamide) nanocarrier encapsulates siRNA via electrostatic interactions to form stable polyplexes.

Simultaneous powder discharge and pipe withdrawal fabricate a braided medical capsule, resolving manufacturing complexity while ensuring structural integrity.

Carboxylated PLGA nanoparticles reduce secondary inflammatory damage and brain edema by skewing immune cell phenotypes toward anti-inflammatory profiles.